BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37256383)

  • 1. Postmastectomy radiotherapy in patients with T
    Luo M; Jin Y; Xu C; Chen H; Zhang K; Chen Q; Jin C; Lu J; Wang J; Huang J; Deng H; Jin W; Zheng S; Chen Y; Zhou J
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):9979-9990. PubMed ID: 37256383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk-adapted postmastectomy radiotherapy based on local-regional recurrence for T1-2N1M0 breast Cancer].
    Li M; Wang SL; Fang H; Tang Y; Chen B; Qi SN; Song YW; Liu YP; Lu NN; Li N; Tang Y; Ren H; Jin J; Li YX
    Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):841-849. PubMed ID: 29151291
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of clinical-pathological factors on locoregional recurrence in mastectomy patients with T1-2N1 breast cancer: who can omit adjuvant radiotherapy?
    Wang X; Zhang L; Zhang X; Luo J; Wang X; Chen X; Yang Z; Mei X; Yu X; Zhang Z; Guo X; Shao Z; Ma J
    Breast Cancer Res Treat; 2021 Nov; 190(2):277-286. PubMed ID: 34490502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic differences and the effect of postmastectomy radiotherapy between post-chemotherapy ypT1-2ypN1 and de novo pT1-2N1 breast cancer.
    Yang T; Zhong X; Wang J; Xiang Z; Zeng Y; Yu S; Dai Z; Xu N; Luo T; Liu L
    Cancer Med; 2023 Apr; 12(7):8112-8121. PubMed ID: 36734308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical Model to Optimize the Strategy of Adjuvant Postmastectomy Radiotherapy in T1-2N1 Breast Cancer With Modern Systemic Therapy.
    Xu FF; Cao L; Xu C; Cai G; Wang SB; Qi WX; Chen JY
    Front Oncol; 2022; 12():789198. PubMed ID: 35280719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of the AJCC 8th edition staging system for selecting patients with T1-2N1 breast cancer for post-mastectomy radiotherapy: a joint analysis of 1986 patients from two institutions.
    Wang S; Wen G; Tang Y; Yang Y; Jing H; Wang J; Zhang J; Zhao X; Sun G; Jin J; Song Y; Liu Y; Fang H; Zhang Y; Li Y
    BMC Cancer; 2020 Aug; 20(1):792. PubMed ID: 32838753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmastectomy Radiotherapy in Patients with pT1-2N1 Breast Cancer Treated with Taxane-Based Chemotherapy: A Retrospective Multicenter Analysis (KROG 1418).
    Kim YJ; Park W; Ha B; Park B; Joo J; Kim TH; Park IH; Lee KS; Lee ES; Shin KH; Kim H; Yu JI; Choi DH; Huh SJ; Wee CW; Kim K; Park KR; Kim YB; Ahn SJ; Lee JH; Kim JH; Chun M; Lee HS; Kim JS; Cha J
    Cancer Res Treat; 2017 Oct; 49(4):927-936. PubMed ID: 28052654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of age as a continuous variable on the prognosis of patients with pT1-2N1 breast cancer.
    Zhao XR; Tang Y; Wu HF; Guo QS; Zhang YJ; Shi M; Cheng J; Wang HM; Liu M; Ma CY; Wen G; Wang XH; Fang H; Jing H; Song YW; Jin J; Liu YP; Chen B; Qi SN; Li N; Tang Y; Lu NN; Zhang N; Li YX; Wang SL
    Breast; 2022 Dec; 66():136-144. PubMed ID: 36270084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The survival benefit of postmastectomy radiotherapy for breast cancer patients with T1-2N1 disease according to molecular subtype.
    Wei J; Jiang Y; Shao Z
    Breast; 2020 Jun; 51():40-49. PubMed ID: 32200207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Most Breast Cancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need Postmastectomy Radiotherapy.
    Muhsen S; Moo TA; Patil S; Stempel M; Powell S; Morrow M; El-Tamer M
    Ann Surg Oncol; 2018 Jul; 25(7):1912-1920. PubMed ID: 29564588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of postmastectomy radiotherapy in clinical T1-3N1M0 breast cancer patients with pathological negative lymph nodes after neoadjuvant chemotherapy and mastectomy].
    Rong QL; Wang SL; Tang Y; Jin J; Song YW; Wang WH; Liu YP; Fang H; Ren H; Liu XF; Yu ZH; Li YX
    Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):445-452. PubMed ID: 28635235
    [No Abstract]   [Full Text] [Related]  

  • 12. Outcome of postmastectomy radiotherapy after primary systemic treatment in patients with clinical T1-2N1 breast cancer.
    Cao L; Ou D; Shen KW; Cai G; Cai R; Xu F; Zhao SG; Xu C; Grellier Adedjouma N; Kirova YM; Chen JY
    Cancer Radiother; 2018 Feb; 22(1):38-44. PubMed ID: 29306555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmastectomy radiotherapy improves disease-free survival of high risk of locoregional recurrence breast cancer patients with T1-2 and 1 to 3 positive nodes.
    He ZY; Wu SG; Zhou J; Li FY; Lin Q; Lin HX; Sun JY
    PLoS One; 2015; 10(3):e0119105. PubMed ID: 25781605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmastectomy radiation therapy and survival outcome in older patients with T1-2N1 breast cancer.
    Luo C; Zhong X; Luo T; Zheng H
    Breast; 2021 Oct; 59():308-313. PubMed ID: 34388696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of postmastectomy radiotherapy on pT
    Guo XY; Sun GY; Wang HM; Liu M; Zhang YJ; Zhang N; Tang Y; Zhao XR; Jing H; Fang H; Wen G; Guo QS; Wu HF; Wang XH; Ma CY; Li YX; Cheng J; Shi M; Wang SL
    Breast; 2022 Feb; 61():108-117. PubMed ID: 34942430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical value of adjuvant radiotherapy in patients with early stage breast cancer with 1 to 3 positive lymph nodes after mastectomy.
    Wu SG; He ZY; Li FY; Wang JJ; Guo J; Lin Q; Guan XX
    Chin J Cancer; 2010 Jul; 29(7):668-76. PubMed ID: 20591219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Post-Mastectomy Radiotherapy in T1-2N1 Breast Cancer Patients: Propensity Score Matched Analysis.
    Kim K; Park W; Kim H; Cho WK; Kim N; Nam SJ; Kim SW; Lee JE; Yu J; Chae BJ; Lee SK; Ryu JM
    Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity in Outcomes of Pathologic T1-2N1 Breast Cancer After Mastectomy: Looking Beyond Locoregional Failure Rates.
    Bazan JG; Majithia L; Quick AM; Wobb JL; Terando AM; Agnese DM; Farrar W; White JR
    Ann Surg Oncol; 2018 Aug; 25(8):2288-2295. PubMed ID: 29916008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of postmastectomy radiotherapy on cT1-2N1 breast cancer patients with ypN0 after neoadjuvant chemotherapy: a retrospective study based on real-world data.
    Dai Y; Ma S; Lan A; Wang Y; Wang Y; Jin Y; Ding N; Jiang L; Tang Z; Yin X; Peng Y; Liu S
    Discov Oncol; 2023 Jan; 14(1):2. PubMed ID: 36609653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomogram Predicting Locoregional Recurrence to Assist Decision-Making of Postmastectomy Radiation Therapy in Patients With T1-2N1 Breast Cancer.
    Luo C; Zhong X; Deng L; Xie Y; Hu K; Zheng H
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(4):905-912. PubMed ID: 30419307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.